ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,720Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 886

$451K Total Retail Price of All Prescriptions

Rank: 60 out of 886

324 Patients Receiving at Least One Drug in Part D
44%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 324 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

34% of this provider’s 324 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 3,191 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 420 159 S3 1 1
LEVOTHYROXINE SODIUM 248 152 2 5
LISINOPRIL 199 81 3 2
GABAPENTIN 199 83 3 8
FUROSEMIDE 187 112 5 10
PRAVASTATIN SODIUM 154 80 6 21
NEXIUM 153 40 7 19
OMEPRAZOLE 153 57 7 4
METOPROLOL TARTRATE 148 50 9 11
POTASSIUM CHLORIDE 146 88 10 17
OXYCODONE HCL 138 12 S2 11 9
SIMVASTATIN 136 78 12 3
METFORMIN HCL 128 58 13 6
CITALOPRAM HBR 121 54 14 16
PROAIR HFA 94 19 15 20
CALCITRIOL 92 44 16 224
HYDROCHLOROTHIAZIDE 91 46 17 12
ATORVASTATIN CALCIUM 89 38 18 32
AMLODIPINE BESYLATE 87 37 19 7
METFORMIN HCL ER 82 20 20 70
RANITIDINE HCL 80 44 21 15
ATENOLOL 79 55 22 23
TRAZODONE HCL 76 17 23 39
AZITHROMYCIN 76 22 23 29
TRAMADOL HCL 75 52 25 24
TIZANIDINE HCL 72 21 26 31
METOPROLOL SUCCINATE 71 38 27 63
CRESTOR 69 44 28 36
FLUOXETINE HCL 67 14 29 50
METOCLOPRAMIDE HCL 66 16 30 145
CLOPIDOGREL 63 29 31 44
GLIMEPIRIDE 62 46 32 47
MELOXICAM 61 38 33 18
ADVAIR DISKUS 59 20 34 61
ESTRADIOL 59 0 R 34 123
GEMFIBROZIL 58 24 36 94
ZOLPIDEM TARTRATE 58 0 36 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 37 38 26
FLUTICASONE PROPIONATE 54 0 39 38
SINGULAIR 52 16 40 76
PREDNISONE 52 13 40 42
POLYETHYLENE GLYCOL 3350 51 17 42 73
PROMETHAZINE HCL 50 0 R 43 41
BENAZEPRIL HCL 50 28 43 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 7, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.